NCT01000025 2023-08-22PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCanadian Cancer Trials GroupPhase 3 Completed720 enrolled 14 charts
NCT00769067 2015-10-07A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy RegimenPfizerPhase 2 Completed188 enrolled 14 charts